Compare PCT & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCT | SLNO |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United States | United States |
| Employees | 157 | N/A |
| Industry | Environmental Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 2.3B |
| IPO Year | N/A | 2014 |
| Metric | PCT | SLNO |
|---|---|---|
| Price | $5.72 | $34.16 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | $13.00 | ★ $108.00 |
| AVG Volume (30 Days) | ★ 4.5M | 1.3M |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 108.90 |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | ★ $1,450,788.00 |
| Revenue This Year | $366.83 | $155.44 |
| Revenue Next Year | $258.25 | $57.99 |
| P/E Ratio | ★ N/A | $94.31 |
| Revenue Growth | N/A | ★ 138.82 |
| 52 Week Low | $5.40 | $32.63 |
| 52 Week High | $17.37 | $89.12 |
| Indicator | PCT | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 27.85 | 32.76 |
| Support Level | N/A | $32.63 |
| Resistance Level | $9.56 | $44.60 |
| Average True Range (ATR) | 0.54 | 2.45 |
| MACD | -0.09 | -0.18 |
| Stochastic Oscillator | 8.54 | 14.19 |
PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.